Corrigendum to “Long-term follow-up of Phase 2A trial results involving advanced ovarian cancer patients treated with Vigil® in frontline maintenance” [Gynecol. Oncol. Rep. 34 (2020) 100648]

Jonathan Oh,Minal Barve,Neil Senzer,Phylicia Aaron,Luisa Manning,Gladice Wallraven,Ernest Bognar,Laura Stanbery,Staci Horvath,Meghan Manley,John Nemunaitis,Adam Walter,Rodney P. Rocconi

Gynecologic oncology reports（2021）

引用 0|浏览7
暂无评分
摘要
[This corrects the article DOI: 10.1016/j.gore.2020.100648.].
更多
查看译文
关键词
advanced ovarian cancer patients,phase 2a trial results,gynecol,corrigendum,frontline maintenance”,long-term
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要